More Adults, Fewer Teens, Are Using Psychedelics, Columbia University Study Finds
[ad_1] Ongoing discussions on whether psychedelics can help treat mental health conditions and improve quality of life have compelled officials and researchers to seek public opinion. All psychedelics are listed as Schedule…
DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
[ad_1] The DEA recently abandoned a proposal for placing five tryptamines as Schedule I under the Controlled Substances Act. Yet the agency is pushing forward to veto two psychedelic drugs named…
HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
[ad_1] Biotech psychedelics company HAVN Life Sciences Inc. HAVLF recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July 21,…
Thai Government Developing Psychedelic Medicine To Treat Various Mental Health Issues, Including Depression
[ad_1] In the face of the national -and worldwide- mental health crisis, the Thailand National Narcotics Control Board recently announced it will commence developing therapeutics extracted from or based on…
Small Pharma Inc.’s New Clinical Study: Understanding The Interaction Of DMT-Assisted Therapy And SSRI Drugs
[ad_1] Short-acting psychedelics company Small Pharma Inc. DMTTF has received the approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee for a drug…